Status:

COMPLETED

Influence of Habitual Protein Intake on AA Tracer Oxidation

Lead Sponsor:

University of Toronto

Conditions:

Protein/Amino Acid Metabolism

Indicator Amino Acid Oxidation Method

Eligibility:

MALE

18-35 years

Phase:

NA

Brief Summary

Protein is an essential nutrient that one's diet to maintain important bodily functions and to recover from exercise. Currently, the Indicator Amino Acid Oxidation method (IAAO) has been used to deter...

Detailed Description

This study employed a two-phase randomized crossover design, where participants performed both a High/Habitual protein phase and a moderate protein phase. The Habitual protein phase is designed to mod...

Eligibility Criteria

Inclusion

  • Healthy, weight-trained individuals that have trained consistently for \> 1 year
  • Habitually dietary protein consumption of 1.9 to 3.0g/kg/d
  • Train each muscle group (i.e. chest, back, legs) at least twice a week
  • Body mass stable in the last month
  • Meets strength relative-to-weight guidelines (adapted from Morton et al., 2016; Chilibeck et -al., 1997)
  • Bench Press: - Bodyweight (kg) \* 1.25
  • Leg Press: - Bodyweight (kg) \*4.0

Exclusion

  • Inability to meet health and PA guidelines according to the PAR-Q+
  • Inability to adhere to any of the protocol guidelines (e.g. alcohol and caffeine consumption)
  • Regular tobacco use, screened by questionnaire
  • Illicit drug use (e.g. growth hormone, testosterone, etc.), screened by a survey in training log
  • 1 month sedentary in the last 6 months prior to study participation
  • 30 minutes of continuous cardio per exercise session
  • BMI \> or equal to 35
  • Individual plans to increase or decrease body mass in the next 3 months
  • Use of supplements (excluding whey protein), such as creatine and beta-alanine, in the last 30 days

Key Trial Info

Start Date :

November 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 18 2018

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT03845569

Start Date

November 1 2017

End Date

April 18 2018

Last Update

February 19 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Goldring Centre for High Performance Sport

Toronto, Ontario, Canada, M5S 2C9